The store will not work correctly when cookies are disabled.
4,4'-(tellurophene-2,5-diyl)dibenzimidamide
ID: ALA4878211
PubChem CID: 164627770
Max Phase: Preclinical
Molecular Formula: C18H16N4Te
Molecular Weight: 415.95
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)[te]2)cc1
Standard InChI: InChI=1S/C18H16N4Te/c19-17(20)13-5-1-11(2-6-13)15-9-10-16(23-15)12-3-7-14(8-4-12)18(21)22/h1-10H,(H3,19,20)(H3,21,22)
Standard InChI Key: AGEGHRKLZZASRR-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
15.5233 -10.5437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5233 -11.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2391 -11.7812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8116 -11.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8116 -12.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0958 -13.0187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0958 -11.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3799 -11.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3799 -12.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6682 -13.0187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5792 -13.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7732 -14.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3607 -13.2934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5384 -13.2086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0578 -13.8740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2355 -13.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8979 -13.0347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0798 -12.9499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7819 -12.1787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5598 -13.5880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3868 -12.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2050 -12.4541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9137 -12.6811 0.0000 Te 0 0 0 0 0 2 0 0 0 0 0 0
1 2 2 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
7 8 1 0
8 9 2 0
6 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
18 20 2 0
17 21 1 0
21 22 2 0
14 22 1 0
13 23 1 0
10 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 415.95 | Molecular Weight (Monoisotopic): 418.0437 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH.. (2019) Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model., 62 (3.0): [PMID:30645099] [10.1021/acs.jmedchem.8b01448] |